Skip Nav Destination
OnlineFirst
September 17 2024
Chemotherapy enriches for pro-inflammatory macrophage phenotypes that support cancer stem-like cells and disease progression in ovarian cancer
Luisjesus S Cruz; Mikella Robinson; Denay Stevenson; Isabella C Amador; Gregory J Jordan; Sofia Valencia; Carolina Navarrete; Carrie D. House
Cancer Research Communications (2024)
September 13 2024
Hypophosphatemia correction reduces ICANS incidence and duration in CAR T-cell therapy: a pooled clinical trial analysis
Jack Pengfei Tang; Penelope Lafeuille; Alexandru Socolov; Sheila S Diamond; Jacob Aptekar; Theodore B. Moore; Esther H Nie; Mark R Hanudel; Theodore S Nowicki
Cancer Research Communications (2024)
September 11 2024
PELP1 is a novel therapeutic target in hepatocellular carcinoma
Khaled Mohamed Nassar; Xue Yang; Adriana Baker; Rahul Gopalam; William C. Arnold; Timilehin T. Adeniran; Marian H. Hernandez Fernandez; Megharani Mahajan; Zhao Lai; Yidong Chen; Gangadhara R. Sareddy; Suryavathi Viswanadhapalli; Lu-Zhe Sun; Ratna K Vadlamudi; Uday P. Pratap
Cancer Research Communications (2024)
September 7 2024
Antiangiogenic tyrosine kinase inhibitors have differential efficacy in clear cell renal cell carcinoma in bone
Stefan Maksimovic; Nina C Boscolo; Ludovica La Posta; Sergio Barrios; Mohammad Jad Moussa; Emanuela Gentile; Pedro I Pesquera; Wenjiao Li; Jianfeng Chen; Javier A Gomez; Akshay Basi; Jared K Burks; Christopher Alvarez-Breckenridge; Jianjun Gao; Matthew T Campbell; Eleonora Dondossola
Cancer Research Communications (2024)
September 6 2024
Combined Oxygen-enhanced MRI and perfusion imaging detect hypoxia modification from banoxantrone and atovaquone and track their differential mechanisms of action
James PB O'Connor; Victoria Tessyman; Ross A Little; Muhammad Babur; Duncan Forster; Ayse Latif; Susan Cheung; Grazyna Lipowska-Bhalla; Geoff S Higgins; Marie-Claude Asselin; Geoff JM Parker; Kaye J Williams
Cancer Research Communications (2024)
September 6 2024
Therapeutic efficacy of IL-7/CCL19-expressing CAR-T cells in intractable solid tumor models of glioblastoma and pancreatic cancer
Keisuke Ohta; Yukimi Sakoda; Keishi Adachi; Taro Shinozaki; Masao Nakajima; Hiroyuki Yasuda; Hiroaki Nagano; Koji Tamada
Cancer Research Communications (2024)
September 6 2024
SREBP-dependent regulation of lipid homeostasis is required for progression and growth of pancreatic ductal adenocarcinoma
Chiaki T Ishida; Stephanie L Myers; Casie S Kubota; Wei Shao; Meredith R McGuire; Chune Liu; Theodore E. Ewachiw; Debaditya Mukhopadhyay; Suqi Ke; Hao Wang; Zeshaan A Rasheed; Robert A. Anders; Peter J Espenshade
Cancer Research Communications (2024)
September 3 2024
NCI's Proteomic Data Commons: A Cloud-Based Proteomics Repository Empowering Comprehensive Cancer Analysis Through Cross-Referencing with Genomic and Imaging Data
Ratna R Thangudu; Michael Holck; Deepak Singhal; Alexander Pilozzi; Nathan Edwards; Paul A Rudnick; Marcin J Domagalski; Padmini Chilappagari; Lei Ma; Yi Xin; Toan Le; Kristen Nyce; Rekha Chaudhary; Karen A Ketchum; Aaron Maurais; Brian Connolly; Michael Riffle; Matthew C. Chambers; Brendan MacLean; Michael J MacCoss; Peter B McGarvey; Anand Basu; John Otridge; Esmeralda Casas-Silva; Sudha Venkatachari; Henry Rodriguez; Xu Zhang
Cancer Research Communications (2024)
September 3 2024
Autofluorescent Cancer Stem Cells: Potential Biomarker to Predict Recurrence in Resected Colorectal Tumor
Sonia Alcala; Gonzalo Serralta San Martin; Marta Muñoz-Fernández de Legaria; Juan Moreno-Rubio; Silvia Salinas; Juan Carlos López-Gil; José Alberto Rojo López; Javier Martínez Alegre; David Abraham Cortes Bandy; Francisco Zambrana; Ana-María Jiménez-Gordo; Enrique Casado; Miriam López-Gómez; Bruno Sainz
Cancer Research Communications (2024)
September 3 2024
MYC is sufficient to generate mid-life high-grade serous ovarian and uterine serous carcinomas in a p53-R270H mouse model
Alexandra Blackman; Amy C Rees; Robert R Bowers; Christian M Jones; Silvia G. Vaena; Madison A Clark; Shelby Carter; Evan D Villamor; Della Evans; Anthony J Emanuel; George Fullbright; Matthew S O'Malley; Richard L. Carpenter; David T Long; Laura S Spruill; Martin J Romeo; Brian C Orr; Kristi L Helke; Joe R Delaney
Cancer Research Communications (2024)
August 30 2024
A drug discovery pipeline for MAPK/ERK pathway inhibitors in C. elegans
Cancer Research Communications (2024)
August 29 2024
Systematic Evaluation of Tyrosine Kinase Inhibitors as OATP1B1 Substrates Using a Competitive Counterflow Screen
Thomas Drabison; Mike Boeckman; Yan Yang; Kevin M Huang; Peter de Bruijn; Mahesh R Nepal; Josie A Silvaroli; Anika T Chowdhury; Eric D Eisenmann; Xiaolin Cheng; Navjotsingh Pabla; Ron H.J. Mathijssen; Sharyn D. Baker; Shuiying Hu; Alex Sparreboom; Zahra Talebi
Cancer Research Communications (2024)
August 28 2024
Engineering oncogenic hotspot mutations on SF3B1 via CRISPR-directed PRECIS mutagenesis
Cancer Research Communications (2024)
August 23 2024
Long-lasting response to lorlatinib in patients with ALK-driven relapsed or refractory neuroblastoma monitored with circulating tumor DNA analysis
Torben Ek; Raghda R Ibrahim; Hartmut Vogt; Kleopatra Georgantzi; Catarina Träger; Jennie Gaarder; Anna Djos; Ida Rahmqvist; Elisabeth Mellström; Fani Pujol-Calderón; Christoffer Vannas; Lina Hansson; Henrik Fagman; Diana Treis; Susanne Fransson; Tobias Österlund; Tzu-Po Chuang; Bronte Manouk Verhoeven; Anders Ståhlberg; Ruth H Palmer; Bengt Hallberg; Tommy Martinsson; Per Kogner; Martin Dalin
Cancer Research Communications (2024)
August 22 2024
Health disparities among cancer patients who received molecular testing for biomarker-directed therapy
Elisabeth Heath; Gregory Dyson; Jennifer R. Ribeiro; Joanne Xiu; Kelsey Poorman; Hirva Mamdani; Mohammed N. Al Hallak; Anthony F. Shields; Jailan A. Elayoubi; Ira S. Winer; Frank C. Cackowski; Gary A. Puckrein; Gilberto de Lima Lopes; Nathaniel Jones; Ralph J. Hauke; Samuel A. Kareff; Milan Radovich; George W. Sledge; David B. Spetzler; Gregory A. Vidal; John L. Marshall
Cancer Research Communications (2024)
August 21 2024
The Proteogenomics of Prostate Cancer Radioresistance
Roni Haas; Gavin Frame; Shahbaz Khan; Beth K Neilsen; Boon Hao Hong; Celestia P.X. Yeo; Takafumi N Yamaguchi; Enya H.W. Ong; Wenyan Zhao; Benjamin Carlin; Eugenia L.L. Yeo; Kah M. Tan; Yuan Zhe Bugh; Chenghao Zhu; Rupert Hugh-White; Julie Livingstone; Dennis J.J. Poon; Pek L. Chu; Yash Patel; Shu Tao; Vladimir Ignatchenko; Natalie J Kurganovs; Geoff S. Higgins; Michelle R Downes; Andrew Loblaw; Danny Vesprini; Amar U Kishan; Melvin L.K. Chua; Thomas Kislinger; Paul C Boutros; Stanley K Liu
Cancer Research Communications (2024)
RSS Feeds